MFA
Mayflower Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $629K | Sell |
1,413
-78
| -5% | -$34.7K | 0.09% | 203 |
|
|
2025
Q1 | $723K | Buy |
1,491
+10
| +0.7% | +$4.85K | 0.11% | 178 |
|
|
2024
Q4 | $596K | Sell |
1,481
-1
| -0.1% | -$403 | 0.09% | 199 |
|
|
2024
Q3 | $689K | Sell |
1,482
-727,830
| -100% | -$338M | 0.1% | 178 |
|
|
2024
Q2 | $1.37M | Buy |
729,312
+173
| +0% | +$325 | 0.22% | 99 |
|
|
2024
Q1 | $1.23M | Buy |
729,139
+27
| +0% | +$45 | 0.21% | 110 |
|
|
2023
Q4 | $1.2M | Sell |
729,112
-23
| -0% | -$38 | 0.17% | 116 |
|
|
2023
Q3 | $1.14M | Sell |
729,135
-425
| -0.1% | -$666 | 0.17% | 112 |
|
|
2023
Q2 | $1.3M | Buy |
729,560
+5
| +0% | +$9 | 0.17% | 112 |
|
|
2023
Q1 | $1.24M | Buy |
729,555
+83
| +0% | +$141 | 0.16% | 114 |
|
|
2022
Q4 | $1.17M | Sell |
729,472
-186
| -0% | -$298 | 0.16% | 106 |
|
|
2022
Q3 | $1.22M | Sell |
729,658
-221,017
| -23% | -$371K | 0.2% | 95 |
|
|
2022
Q2 | $1.14M | Buy |
950,675
+32
| +0% | +$38 | 0.17% | 103 |
|
|
2022
Q1 | $1.12M | Buy |
950,643
+390,581
| +70% | +$459K | 0.15% | 105 |
|
|
2021
Q4 | $664K | Buy |
560,062
+251
| +0% | +$298 | 0.09% | 158 |
|
|
2021
Q3 | $601K | Buy |
559,811
+14
| +0% | +$15 | 0.08% | 169 |
|
|
2021
Q2 | $602K | Sell |
559,797
-60
| -0% | -$65 | 0.08% | 150 |
|
|
2021
Q1 | $618K | Buy |
+559,857
| New | +$618K | 0.09% | 143 |
|